These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6147806)

  • 41. [Experimental studies with timolol: a new ocular hypotensive agent (author's transl)].
    Vareilles P; Schmitt C; Lotti VJ; Le Douarec JC
    J Fr Ophtalmol; 1978 Dec; 1(12):717-21. PubMed ID: 155095
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The influence of 0.85% RS-timolol and 0.5% S-timolol on intraocular pressure and systemic arterial blood pressure, heart rate, ECG, expiratory capacity in patients with ocular hypertension and primary open-angle glaucoma].
    Czechowicz-Janicka K; Staszkiewicz J; Strzałkowska M; Krajewska M; Popiołek B; Christman A
    Klin Oczna; 1999; 101(5):333-7. PubMed ID: 10714069
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucoma.
    Gupta SK; Agarwal R; Galpalli ND; Srivastava S; Agrawal SS; Saxena R
    Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):665-71. PubMed ID: 18200329
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of haloperidol, a dopamine antagonist, on intraocular pressure in experimental glaucoma.
    Khosla P; Kothari S; Gupta MC; Srivastava RK
    Indian J Exp Biol; 1996 Jun; 34(6):580-1. PubMed ID: 8792645
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics and intraocular pressure lowering effect of timolol preparations in rabbit eyes.
    Chiang CH; Ho JI; Chen JL
    J Ocul Pharmacol Ther; 1996; 12(4):471-80. PubMed ID: 8951683
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A double-masked randomized crossover study comparing the effect of latanoprost/timolol and brimonidine/timolol fixed combination on intraocular pressure and ocular blood flow in patients with primary open-angle glaucoma or ocular hypertension.
    Hommer A; Sperl P; Resch H; Popa-Cherecheanu A; Qiao C; Schmetterer L; Garhöfer G
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):569-75. PubMed ID: 22775229
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Sezgin Akçay Bİ; Güney E; Bozkurt KT; Unlü C; Akçali G
    J Ocul Pharmacol Ther; 2013 Dec; 29(10):882-6. PubMed ID: 24180628
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Melatonin and its analog 5-methoxycarbonylamino-N-acetyltryptamine potentiate adrenergic receptor-mediated ocular hypotensive effects in rabbits: significance for combination therapy in glaucoma.
    Crooke A; Huete-Toral F; Martínez-Águila A; Martín-Gil A; Pintor J
    J Pharmacol Exp Ther; 2013 Jul; 346(1):138-45. PubMed ID: 23591996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of latanoprost or fixed-combination latanoprost-timolol in patients switched from a combination of timolol and a nonprostaglandin medication.
    Magacho L; Reis R; Shetty RK; Santos LC; Avila MP
    Ophthalmology; 2006 Mar; 113(3):442-5. PubMed ID: 16458964
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of dopamine agonist, bromocriptine, and some dopamine antagonists on ocular blood flow.
    Chiou GC; Chen YJ
    J Ocul Pharmacol; 1992; 8(4):285-94. PubMed ID: 1484260
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ocular hypotensive actions of serotonin antagonist-ketanserin analogs.
    Chiou GC; Li BH
    J Ocul Pharmacol; 1992; 8(1):11-21. PubMed ID: 1402292
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of L-timolol, D-timolol, haloperidol and domperidone on rabbit retinal blood flow measured with laser Doppler method.
    Yan HY; Chiou GC
    Ophthalmic Res; 1987; 19(1):45-8. PubMed ID: 3299200
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of neuroleptic butyrophenones on pituitary-adrenal activity in rats.
    Aimoto T; Kaida M; Sato M; Sato M; Kimura R; Murata T
    J Pharmacobiodyn; 1980 Jan; 3(1):46-52. PubMed ID: 6110713
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dopamine-2 receptor blockade does not affect the ocular hypotensive action of timolol.
    Mekki QA; Turner P
    Br J Ophthalmol; 1988 Aug; 72(8):598-600. PubMed ID: 3415954
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oral haloperidol lowers human intraocular pressure.
    Sheppard JD; Schaid DJ
    J Ocul Pharmacol; 1986; 2(3):215-24. PubMed ID: 3503108
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Biopharmaceutical studies on neuroleptic butyrophenones. IV. Sex differences in the disposition of clofluperol in the rat (author's transl)].
    Aimoto T; Masuda C; Murata T
    Yakugaku Zasshi; 1979 Aug; 99(8):851-4. PubMed ID: 541776
    [No Abstract]   [Full Text] [Related]  

  • 57. [2 NEW HIGHLY ACTIVE NEUROLEPTICS].
    GUENTHER M
    Hippokrates; 1964 Oct; 35():IV-VI. PubMed ID: 14325443
    [No Abstract]   [Full Text] [Related]  

  • 58. The evolution of the butyrophenones, haloperidol and trifluperidol, from meperidine-like 4-phenylpiperidines.
    Janssen PA
    Int Rev Neurobiol; 1965; 8():221-63. PubMed ID: 5321473
    [No Abstract]   [Full Text] [Related]  

  • 59. Is topical haloperidol a useful glaucoma treatment?
    Lavin MJ; Andrews V
    Br J Ophthalmol; 1986 Jun; 70(6):448-50. PubMed ID: 3718908
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.